The Changing Face of Osmotic Demyelination Syndrome: A Retrospective, Observational Cohort Study.
Publication/Presentation Date
8-1-2021
Abstract
OBJECTIVE: To describe the long-term outcomes of osmotic demyelination syndrome (ODS) in an updated cohort.
METHODS: We performed a retrospective medical records review of cases of ODS at the Massachusetts General and Brigham and Women's Hospitals using International Classification of Diseases-9th edition codes and a text-based search for
RESULTS: We identified 45 cases of ODS (mean age 48.4 years, range 0.07-75 years; 58% female patients). Common comorbidities included liver disease (27%, n = 12), alcoholism (44%, n = 20), and kidney failure (20%, n = 9). Twenty-nine percent of patients had a rapid correction of hyponatremia. Twenty-nine percent had other electrolyte abnormalities. Only 59% (24/41) of patients with complete electrolyte data had abnormalities that could explain their ODS. At the 6-month follow-up, 16% of the patients were dead and 60% of patients had minimal-to-no disability (mRS 0-2).
CONCLUSIONS: ODS has a diverse range of clinical presentations. Not all patients have electrolyte abnormalities. The prognosis is generally favorable, although 1 in 6 patients had died at 6 months, likely because of underlying disease states.
Volume
11
Issue
4
First Page
304
Last Page
310
ISSN
2163-0402
Published In/Presented At
Fitts, W., Vogel, A. C., & Mateen, F. J. (2021). The Changing Face of Osmotic Demyelination Syndrome: A Retrospective, Observational Cohort Study. Neurology. Clinical practice, 11(4), 304–310. https://doi.org/10.1212/CPJ.0000000000000932
Disciplines
Medicine and Health Sciences
PubMedID
34484930
Department(s)
Department of Pediatrics
Document Type
Article